Key Insights: EU Imports of e-Cigarettes from China Reached €3.3 Billion, weighing 56,000 Tons in 2022

Sep.25.2023
Key Insights: EU Imports of e-Cigarettes from China Reached €3.3 Billion, weighing 56,000 Tons in 2022
China's e-cigarette exports to the EU reached approximately 3.3 billion euros in 2022, with 59% coming from China.

Important information


In 2022, the European Union imported approximately 3.3 billion euros worth of e-cigarettes from 27 countries, with a total weight of 56,000 tons. China accounted for 59% of the total imports.


In August 2023, China's e-cigarette export to the United States reached a total value of 255 million US dollars (approximately 1.858 billion Chinese Yuan), witnessing a 3.05% decrease compared to the previous month and a 3.03% increase on a year-on-year basis.


In July 2023, China's e-cigarette exports to the Netherlands increased by 19% to 195 million yuan compared to the previous year. However, there was a sequential decrease of 10.59% from the previous month. On a year-on-year basis, there was a growth of 19.35%.


In July 2023, China's e-cigarette exports to the United Arab Emirates increased by 39% to reach 110 million yuan. The export quantity also rose by 93%, reaching 373,167 kilograms.


The US Food and Drug Administration (FDA) has issued warning letters to 15 e-cigarette online retailers and three manufacturers (distributors), urging them to cease the sale or distribution of unauthorized e-cigarette products.


The Center for Tobacco Products (CTP) of the US FDA is currently soliciting representatives from the tobacco manufacturing industry to join the Tobacco Products Scientific Advisory Committee. The deadline for applications is October 11.


Philip Morris International (PMI) is considering selling a portion of its largest pharmaceutical division, Vectura, due to its failure to meet profit expectations for the past two years.


The number of intellectual property applications made by KT&G, both domestically and internationally, has sharply risen from 27 cases in 2017 to 1,065 cases projected for 2022, marking a staggering growth rate of more than 3,800 percent. Additionally, the total number of registered trademarks has reached 7,132.


ISPIRE's revenue for the fiscal year 2023 has increased by 31.2%, reaching $115.6 million. This growth can be attributed to the significant increase in revenue from CBD vaporization products, which saw a growth of 100.4% and reached $40 million. Additionally, revenue from e-cigarette products grew by 10.9%, reaching $75.6 million.


The German e-cigarette trade association (VdeH) has reported a decline of approximately one-third in the number of physical sales points for e-cigarette specialty retail stores in Germany, now standing at approximately 1,200.


The sales of non-combustible pod products in South Korea have seen a tremendous growth, increasing by 6.8 times from 78.7 million boxes in 2017 to 538.6 million boxes last year. In just the first half of this year (January to June), sales have already reached 292.6 million boxes. It is projected that by the end of 2023, annual sales will surpass 600 million boxes for the first time.


Special Report on GTNF


The Global Tobacco and Nicotine Forum (GTNF) opened on September 19, 2023, and 2FIRSTS arrived on the scene to provide coverage. The theme for the first day of the forum was "Consumer First." Attendees discussed various focal points such as the enforcement status of the US FDA, the future of safe nicotine products in the US, the ease of consumer access to compliant products after market regulations, and how the e-cigarette industry plans to assist consumers.


On the second day of the 2023 Global Tobacco and Nicotine Forum (GTNF), Nancy Loucas, Coordinator for Public Health Policy and Implementation at CAPHRA, spoke to 2FIRSTS and highlighted contrasting trends in smoking rates in Australia and New Zealand. Despite Australia's implementation of stringent healthcare measures, smoking rates have remained stagnant or even increased. In contrast, New Zealand has successfully managed to reduce its smoking rates.


Dr. Deng Ming, the head of the research on the emerging tobacco industry at Yunnan University, discussed the future of e-cigarettes during his speech at GTNF. He emphasized that the upcoming trend in e-cigarettes will involve the combination of heating without combustion technology with vapes, similar to the "Lil AIBLE" product by KT&G, a South Korean tobacco company.


At the GTNF forum, participants engaged in discussions on the topics of "the path to sustainable development" and "directions for new product development". Some guests expressed the belief that products beyond nicotine may be the future trend.


During a speech at the GTNF forum, Julian Cheung, the Asia Pacific Director of Operations for JTI, highlighted the staggering figures surrounding the global illicit tobacco trade. Cheung revealed that in 2022, the value of this illegal trade reached a staggering $40 trillion, with counterfeit tobacco products accounting for a significant 33.9% of the total global cigarette production.


Vaporesso (a brand under Smoore), Innokin, ICCPP (a subsidiary of the Ji'en Group), ANDS, Alliance One India Industries (AOII), and The Center for Agricultural Transformation (CAT) have been awarded the Golden Leaf Prize for the year 2023.


Brian King, Director of the Tobacco Center at the Food and Drug Administration (FDA), stated in an interview with 2FIRSTS that submitting a PMTA application for e-cigarette products is not equivalent to being able to legally sell them.


During the GTNF forum, Brian King, Director of the Center for Tobacco Products at the U.S. FDA, expressed his concerns about how the FDA can adapt to the evolving category of e-cigarettes and improve the predictability of regulations. In response, Brian A. King stated that the FDA is highly supportive of e-cigarette innovation and will strive to adapt to these changes in order to facilitate the entry of innovative e-cigarette products into the U.S. market.


Australian smoking expert Dr. Colin Mendelsoh recently spoke with 2FIRSTS, where he expressed his view that Australia's prescription e-cigarette model has been a failure.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American are rolling out smoke-free products without FDA approval due to delays. They highlight that illegal e-cigarettes, with candy flavors, are gaining market share while legal products await approval. Altria will release a new nicotine pouch in select states, and Reynolds will launch a disposable e-cigarette. Advocates fear these unauthorized products may attract new users and harm youth.
Sep.01 by 2FIRSTS.ai
CHUC Announces $2 Million Financing to Fuel Expansion of "Nicotine-Free" E-Cigarette SBX
CHUC Announces $2 Million Financing to Fuel Expansion of "Nicotine-Free" E-Cigarette SBX
Charlie's Holdings, Inc. (CHUC) secured a $2 million credit agreement with independent director Michael D. King to expand its nicotine-free SBX product. Early sales in the U.S. Southeast exceeded expectations, with the product being legal and popular nationwide. Funds will boost inventory and convenience store presence. CHUC has also sold 16 PACHA-related assets to Reynolds in three deals.
Aug.28 by 2FIRSTS.ai
Study: Specialist e-cigarette stores in Western Australia close after new federal regulations, but convenience stores continue illegal sales
Study: Specialist e-cigarette stores in Western Australia close after new federal regulations, but convenience stores continue illegal sales
A study led by the University of Notre Dame Australia reveals that since the 2024 e-cigarette regulations, all 117 specialized e-cigarette stores in Western Australia have closed, and 76 other shops have stopped selling e-cigarettes. However, some central Perth convenience stores continue to sell them illicitly. Experts warn this undermines the regulations and call for increased monitoring, stricter enforcement, and higher penalties.
Sep.03 by 2FIRSTS.ai
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Caught between banning and not banning, the Russian government finds itself in a dilemma. The vape market generates substantial tax revenue, yet raises public health concerns. Lawmakers are applying pressure—some even suggest “following China”—as a regulatory storm quietly gathers.
Aug.22
UK MHRA Approved E-cigarette Products List Updated | 46 SKUs Approved, INNOKIN Submits New Products Across Multiple Categories(9.1 - 9.7)
UK MHRA Approved E-cigarette Products List Updated | 46 SKUs Approved, INNOKIN Submits New Products Across Multiple Categories(9.1 - 9.7)
The Medicines and Healthcare products Regulatory Agency (MHRA) database was updated with 46 e-cigarette SKUs from September 1-7, with Shenzhen INNOKIN Technology Co., Ltd. (INNOKIN) being the most active, having multiple new devices and pods approved. Meanwhile, although the number of updates has decreased, pre-filled pods remain the most approved category this week.
Sep.08
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
The latest data show that in 2024, disposable vape sales in Nova Scotia grew by 25%, and about 16% of residents use vaping products—signaling strong demand for tobacco alternatives. The province’s regulatory framework is forcing retailers to accelerate product-line adjustments and compliance upgrades.
Sep.23 by 2FIRSTS.ai